Professional Role · Topic 3 of 21

Prescriptive Authority & Controlled Substances

Professional role · prescribing law

Prescriptive Authority & Controlled Substances

Controlled-substance prescribing needs state authority plus a DEA registration; Schedule II never refills, and buprenorphine needs no waiver.

Key numbers

State authority plus DEA registration requiredDEA renewal: 3 years

Schedule II: no refills everC-II refills: 0

Schedules III–IV: 5 refills within 6 months≤ 5 refills / 6 months

No X-waiver; one-time 8-hour MATE training8 h, one time

01 · The ruleState authority plus DEA registration required

Prescribing controlled substances requires state prescriptive authority plus a DEA registration in each state of practice, renewed every 3 years; the DEA registration covers only the schedules state law allows the NP.

02 · The ruleSchedule II: no refills ever

Schedule II prescriptions can never be refilled; a prescriber may write multiple prescriptions totalling up to a 90-day supply, and an emergency oral order requires a written prescription to the pharmacy within 7 days.

03 · The ruleNo X-waiver; one-time 8-hour MATE training

The X-waiver ended December 29, 2022: any DEA registrant may prescribe buprenorphine for OUD with no patient cap. Since June 27, 2023, every DEA registrant attests once to 8 hours of substance-use-disorder training (MATE Act).

The rules

Know these

Schedules III–IV: 5 refills within 6 months must knowSchedule III and IV prescriptions may be refilled no more than 5 times and not filled or refilled more than 6 months after the date issued.

Acute pain: lowest dose, shortest courseFor acute pain, prescribe immediate-release opioids at the lowest effective dose and no greater quantity than the expected duration of severe pain — a few days or less is often enough.

Practice environment sets controlled-substance authorityIn full practice states NPs prescribe, including controlled substances, under board-of-nursing authority alone; reduced or restricted states may require a collaborative or supervisory agreement for prescribing.

Hospital NPs may use the hospital's DEA numberA hospital-employed NP acting within employment may prescribe under the hospital's DEA registration with an assigned internal suffix code, if state law permits; a personal registration is needed for prescriptions outside that role.

Medicare Part D: e-prescribe Schedules II–VThe SUPPORT Act requires Medicare Part D Schedule II–V prescriptions to be sent electronically (EPCS); since 2023 prescribers comply when at least 70% of such claims are e-prescribed, with small-prescriber and waiver exceptions.

What it is

Core idea

Schedules I–V: abuse potential falls I→V must knowSchedule I has no accepted medical use; Schedule II has high abuse potential (oxycodone, fentanyl, hydromorphone, methadone, amphetamines); III (ketamine, testosterone, codeine combinations, buprenorphine), IV (benzodiazepines, zolpidem, tramadol) and V carry progressively less.

Management

Orders

Check the PDMP before prescribing opioidsReview the state PDMP before every opioid prescription when feasible — at minimum before an initial prescription and at least every 3 months during long-term therapy; many state laws mandate PDMP checks.

Offer naloxone with every opioid prescriptionOffer naloxone when prescribing opioids, especially with prior overdose, substance use disorder, sleep-disordered breathing, doses ≥ 50 MME/day, or concurrent benzodiazepines.

Red flags & don'ts

Avoid harm

Avoid combining opioids with benzodiazepines avoidUse particular caution prescribing benzodiazepines or other sedatives with opioids — the combination raises overdose risk and is a reason to offer naloxone.

Schedule II or Schedule III–IV prescription?

Commonly confused

Examples	Oxycodone, fentanyl, hydromorphone, methadone, amphetamines
Refills	Never
Time limit	Multiple prescriptions may cover up to a 90-day supply
Oral (phone) order	Emergency only; written prescription within 7 days

More detail

Reference

Show 5 reference facts

The Ryan Haight Act normally requires an in-person exam before controlled-substance prescribing by telemedicine; DEA/HHS COVID-era flexibilities are extended through December 31, 2026.

MATE training is deemed met by addiction medicine/psychiatry board certification or graduation from an APRN, PA, medical or dental program within 5 years of June 27, 2023 with ≥ 8 hours of SUD curriculum.

Reassess patients on long-term opioid therapy at least every 3 months, and more often for those at higher risk of opioid use disorder or overdose.

DEA regulations call NPs and PAs 'mid-level practitioners'; their registration authority is limited to what the state of practice allows.

State buprenorphine laws still apply after the X-waiver's repeal, so state-specific limits may remain.

Pearl

State law says whether you may prescribe it; the DEA says how — and Schedule II never gets a refill.

Sources · 21 CFR 1301.12 — Separate registrations for separate locations (eCFR via Cornell LII) · 21 CFR 1301.13 — Application for registration; registration period (practitioner: 3 years; mid-level practitioner) (eCFR via Cornell LII) · AANP — State Practice Environment (full practice includes prescribing controlled substances) · DEA — Drug Scheduling · 21 CFR 1306.12 — Refilling prescriptions; issuance of multiple prescriptions (Schedule II) (eCFR via Cornell LII) · 21 CFR 1306.11 — Requirement of prescription (Schedule II emergency oral prescriptions) (eCFR via Cornell LII) · 21 CFR 1306.22 — Refilling of prescriptions (Schedules III and IV) (eCFR via Cornell LII) · DEA Diversion Control — Dear Registrant letter on elimination of the DATA-Waiver (Jan 12, 2023) · DEA Diversion Control — MATE Act training requirement letter to registrants · Dowell D et al. CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022. MMWR Recomm Rep 2022;71(3):1–95 · AANP — State Practice Environment (full, reduced and restricted practice) · 21 CFR 1301.22 — Exemption of agents and employees (practitioners using a hospital registration) (eCFR via Cornell LII) · CMS — Electronic Prescribing for Controlled Substances (EPCS) Program · DEA/HHS — Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications (Federal Register, Dec 31, 2025) · PALTmed — DEA and HHS extend telemedicine controlled-substance prescribing flexibilities through Dec 31, 2026 · 21 CFR 1308.13 — Schedule III (includes buprenorphine) (eCFR via Cornell LII) · Starter sheet built from the verified AGACNP fact map (facts reviewed 2026-10-15).